Detalhe da pesquisa
1.
Early-life caffeine exposure induces morphological changes and altered physiology in Caenorhabditiselegans.
Biochem Biophys Res Commun
; 690: 149240, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988878
2.
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network.
Genome Res
; 29(2): 184-192, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651280
3.
Neuropathology of murine Sanfilippo D syndrome.
Mol Genet Metab
; 134(4): 323-329, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34844863
4.
Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome.
Mol Genet Metab
; 133(2): 185-192, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33839004
5.
Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice.
Mol Pharm
; 18(1): 214-227, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320673
6.
Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I.
Mol Genet Metab
; 129(2): 91-97, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630958
7.
Intrathecal enzyme replacement for cognitive decline in mucopolysaccharidosis type I, a randomized, open-label, controlled pilot study.
Mol Genet Metab
; 129(2): 80-90, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31839529
8.
Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes.
Genet Med
; 21(11): 2552-2560, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31019279
9.
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB.
Proc Natl Acad Sci U S A
; 111(41): 14870-5, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267636
10.
Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I.
Mol Genet Metab
; 116(1-2): 69-74, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260077
11.
Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts.
Biochem J
; 458(2): 281-9, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266751
12.
Does a dose relationship exist with prothrombin complex and factor Xa inhibitor reversal? An alternate perspective of Yohe et al.
Am J Emerg Med
; 38(3): 686-687, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31522926
13.
Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
Mol Genet Metab
; 112(4): 286-93, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24951454
14.
Combining angiotensin receptor blockade and enzyme replacement therapy for vascular disease in mucopolysaccharidosis type I.
Mol Genet Metab Rep
; 38: 101036, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38173710
15.
GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice.
bioRxiv
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585903
16.
Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients.
Pediatr Res
; 74(6): 712-20, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24002329
17.
Factors determining whether diffuse large B-cell lymphoma samples are detected by flow cytometry.
Int J Lab Hematol
; 45(6): 927-934, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632200
18.
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I.
Mol Genet Metab
; 106(1): 68-72, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22402327
19.
Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease.
Mol Ther Methods Clin Dev
; 27: 452-463, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36419468
20.
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep.
J Clin Invest
; 132(20)2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040802